Da32 Competitors

Delisted . USA . 
Stock . Da32 Life Science
DALSDelisted Stock  USD 10.29  0.00  0.00%   
Analyzing Da32 Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Da32 Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Da32 Life competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
10.2910.2910.29
Details
Intrinsic
Valuation
LowRealHigh
8.738.7311.32
Details

Da32 Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Da32 Life and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Da32 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Da32 Life Science does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
OPA
+ 0.83
CPAA
CPAA
+ 0.79
DTOC
ITAQ
+ 0.68
DTOC
CPAA
+ 0.66
ITAQ
OPA
+ 0.65
DTOC
OPA
+ 0.55
ITAQ
  
High negative correlations   
ENCP
- 0.35
OPA
ENCP
- 0.32
CPAA
ENCP
- 0.07
DTOC
LGVC
- 0.0
GENQ

Risk-Adjusted Indicators

There is a big difference between Da32 Stock performing well and Da32 Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Da32 Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Da32 Life Competitive Analysis

The better you understand Da32 Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Da32 Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Da32 Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DALS DTOC GENQ ITAQ LGVC CPAA OPA
 0.00 
 10.29 
Da32
 0.00 
 10.48 
Digital
 0.29 
 10.47 
Genesis
 0.00 
 10.62 
Industrial
 0.00 
 10.51 
LAMF
 0.00 
 10.25 
Conyers
 0.00 
 10.49 
Magnum
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
Dangerous
Dangerous
Dangerous
Dangerous
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Not Rated
Not Rated
Not Rated
Not Rated
Not Rated
Current Ratio
8.61 X
0.74 X
3.69 X
4.12 X
14.72 X
5.09 X
N/A
Net Asset
203.86 M
338.88 M
89.1 M
179.15 M
32.35 M
361.83 M
203.76 M
EBITDA
(4.66 M)
(11.21 M)
(2.85 M)
(5.97 M)
(8.65 M)
(11.33 M)
(21.7 M)
Current Valuation
263.63 M
107.14 M
85.25 M
61.57 M
102.18 M
458.74 M
125.05 M
Price To Book
N/A
1.29 X
1.32 X
1.28 X
7.53 X
1.28 X
2.33 X
Retained Earnings
(4.74 M)
(14.2 M)
(3.16 M)
(7.16 M)
(18.91 M)
(2.25 B)
(11.89 M)
Beta
N/A
0.0239
N/A
N/A
-0.032
N/A
0.007
Number Of Employees
2
2
4
2
2
4
3
Shares Outstanding
20.65 M
10.11 M
5.87 M
1.35 M
12.49 M
35.7 M
6.6 M
Cash Flow From Operations
(1.1 M)
(795.65 K)
(1.07 M)
(1.38 M)
(789.83 K)
(994.54 K)
(1.6 M)
Total Debt
200 K
N/A
250 K
127.39 K
650
2.02 B
295.9 K
Return On Equity
N/A
N/A
N/A
N/A
N/A
N/A
0.14
Z Score
N/A
-0.18
N/A
N/A
N/A
2.52
N/A
Return On Asset
-0.0054
-0.0154
-0.02
-0.0107
-0.0363
-0.0018
-0.0226
Number Of Shares Shorted
1.87 K
886
695
104
15.79 K
9.77 K
172
Book Value Per Share
(0.20) X
(1.00) X
(0.52) X
(1.71) X
(1.48) X
(0.26) X
(1.20) X
Total Asset
203.86 M
338.88 M
89.1 M
179.15 M
32.35 M
361.83 M
203.76 M
Short Ratio
0.05 X
0.40 X
0.04 X
0.02 X
0.12 X
0.08 X
0.01 X
Debt To Equity
N/A
N/A
N/A
6.00 %
N/A
3.25 %
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
15.0
Shares Owned By Institutions
92.98 %
24.37 %
93.80 %
100.00 %
7.60 %
83.50 %
93.11 %
Market Capitalization
264.2 M
106.84 M
84.01 M
61.99 M
101.31 M
458.74 M
125.17 M
Price To Earning
N/A
57.76 X
N/A
67.07 X
N/A
60.81 X
67.64 X
Price To Sales
N/A
N/A
N/A
N/A
1,000,000 X
N/A
N/A
Net Income
599.22 K
10.53 M
(519.8 K)
4.89 M
(3.49 M)
7.87 M
15.27 M
Earnings Per Share
0.06 X
0.05 X
(0.07) X
0.15 X
(0.17) X
0.17 X
0.62 X
Shares Owned By Insiders
7.02 %
81.86 %
9.49 %
N/A
24.62 %
N/A
N/A
Revenue
N/A
N/A
N/A
N/A
N/A
4.05 B
N/A
Working Capital
(121.07 K)
(2.14 M)
(903.26 K)
(292.76 K)
(5.71 M)
1.28 M
(6.02 M)
Cash And Equivalents
1.1 M
290.71 K
364.02 K
745.69 K
643.11 K
1.16 M
24.57 K
Cash Per Share
0.04 X
0.01 X
0.03 X
0.04 X
0.02 X
0.03 X
N/A
Day Typical Price
10.29
10.48
10.51
10.62
10.58
10.25
10.49
Accumulation Distribution
N/A
N/A
0.0536
N/A
0.0223
0.0019
N/A
Market Facilitation Index
N/A
N/A
0.58
N/A
0.24
0.02
N/A
Daily Balance Of Power
0.0
0.0
(0.05)
0.0
N/A
N/A
0.0
Period Momentum Indicator
N/A
N/A
(0.03)
N/A
N/A
N/A
N/A
Rate Of Daily Change
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Day Median Price
10.29
10.48
10.53
10.62
10.62
10.25
10.49
Price Action Indicator
N/A
N/A
(0.07)
N/A
(0.11)
N/A
N/A
Coefficient Of Variation
1422.87
635.47
(1,102)
1130.36
7323.84
542.31
1243.6
Mean Deviation
0.1562
0.1432
0.234
0.1823
0.3659
0.0665
0.2269
Jensen Alpha
0.0048
0.025
(0.05)
N/A
(0.01)
0.0089
0.0412
Total Risk Alpha
(0.03)
(0.01)
(0.14)
(0.03)
(0.15)
(0.01)
(0.05)
Sortino Ratio
(0.40)
(0.19)
N/A
(0.25)
(0.09)
(0.88)
(0.13)
Downside Variance
0.0812
0.2322
N/A
0.162
1.73
0.0169
0.5263
Standard Deviation
0.2356
0.2534
0.5187
0.3318
0.9794
0.0889
0.4876
Kurtosis
1.56
4.39
11.5
6.22
19.52
1.34
18.59
Potential Upside
0.4888
0.5831
0.282
0.6744
0.6731
0.1955
0.5803
Treynor Ratio
0.4555
0.7375
3.05
N/A
0.0424
(0.31)
(0.29)
Maximum Drawdown
1.18
1.65
2.46
2.3
9.8
0.2959
4.86
Variance
0.0555
0.0642
0.269
0.1101
0.9591
0.0079
0.2377
Market Risk Adjusted Performance
0.4655
0.7475
3.06
N/A
0.0524
(0.30)
(0.28)
Risk Adjusted Performance
0.0313
0.1001
(0.07)
0.0546
0.0126
0.0649
0.0558
Skewness
0.5724
0.5038
(1.23)
1.51
0.9924
(0.35)
(0.61)
Semi Deviation
0.1172
0.0
N/A
0.1066
0.7338
0.0
0.3569
Information Ratio
(0.48)
(0.36)
(0.34)
(0.30)
(0.12)
(1.28)
(0.19)
Value At Risk
(0.29)
(0.20)
(0.83)
(0.47)
(0.66)
(0.1)
(0.29)
Expected Short fall
(0.27)
(0.40)
N/A
(0.46)
(0.68)
(0.12)
(0.40)
Downside Deviation
0.2849
0.4819
N/A
0.4025
1.32
0.1301
0.7255
Semi Variance
0.0137
(0.01)
N/A
0.0114
0.5384
(0.01)
0.1274

Da32 Life Competition Performance Charts

Five steps to successful analysis of Da32 Life Competition

Da32 Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Da32 Life Science in relation to its competition. Da32 Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Da32 Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Da32 Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Da32 Life Science, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Da32 Life position

In addition to having Da32 Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Da32 Stock

If you are still planning to invest in Da32 Life Science check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Da32 Life's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY